Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73M
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
52.6M
-
Shares change
-
+2.88M
-
Total reported value, excl. options
-
$1.73B
-
Value change
-
+$92.8M
-
Put/Call ratio
-
4.59
-
Number of buys
-
97
-
Number of sells
-
-55
-
Price
-
$32.80
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q2 2023
181 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.6M shares
of 73M outstanding shares and own 72.05% of the company stock.
Largest 10 shareholders include FMR LLC (8.55M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.95M shares), BlackRock Inc. (3.23M shares), CITADEL ADVISORS LLC (2.79M shares), Capital International Investors (2.73M shares), VANGUARD GROUP INC (2.38M shares), LORD, ABBETT & CO. LLC (2.32M shares), JANUS HENDERSON GROUP PLC (1.77M shares), GOLDMAN SACHS GROUP INC (1.57M shares), and Holocene Advisors, LP (1.54M shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.